About Course #L0759
Release Date: July 20, 2016
Expiration Date: July 19, 2019
This intermediate-level course reviews the history, pharmacology, and contemporary techniques of N2O/O2 sedation in the dental setting, discusses the continuum of consciousness and examines where N2O/O2 sedation may fit in the treatment paradigm. This course will also fill gaps in knowledge concerning patient selection, regulations, contraindications, and techniques for appropriate administration in certain special populations requiring advanced consideration. The principles learned will be directly applicable in determining the most suitable approach for the cardiac, pregnant, and breast-feeding patient, and will help to address staff concerns around potential environmental risks.
Since the goal of any successful procedure is to ensure selection of the right drug at the right time and at the right dose, for the right patient and the right procedure, the information presented in this intermediate-level course should be considered essential knowledge for all oral healthcare practitioners.
AGD Subject Code: 132
- Describe the history, pharmacology, and physical properties of nitrous oxide-oxygen inhalational sedation.
- Explain the effects of nitrous oxide-oxygen on physiological systems.
- Outline the administration of nitrous oxide-oxygen inhalational sedation in the dental office.
- Discuss the complications of nitrous oxide-oxygen inhalational sedation.
Western Schools designates this activity for 3 continuing education credits.
New Jersey (RDH and RDA) - Fulfills nitrous oxide requirement.
About the Author(s)
Mark Donaldson, BSP, RPH, PharmD, ACPR, FASHP, FACHE, received his baccalaureate degree from the University of British Columbia and his doctorate in clinical pharmacy from the University of Washington. He has further completed a residency at Canada's largest tertiary care facility, Vancouver General Hospital, and is the current Director of Pharmacy Clinical Services at Vizient. Dr. Donaldson is a clinical professor in the Department of Pharmacy at the University of Montana in Missoula, and clinical associate professor in the School of Dentistry at the Oregon Health and Science University in Portland. He has a special interest in dental pharmacology and has lectured internationally to both dental and medical practitioners. Dr. Donaldson has a number of published works in the peer-reviewed literature and has co-authored textbook chapters. He spent three years in Japan focusing on cross-cultural communication and internationalization. He currently serves on the Editorial Board for The Journal of the American Dental Association (JADA), is board-certified in healthcare management, and is the past president of the American College of Healthcare Executives' Montana Chapter. In 2016 he was recognized by the Academy of General Dentistry as the recipient of the Dr. Thaddeus V. Weclew Award for outstanding contributions to the art and science of dentistry and/or enhanced the principles and ideals of the Academy.
- Courses must be completed on or before the expiration date noted in the course description above.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
- Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools' policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.